
Acuren Corporation Announces Results for the First Quarter 2025
The presentation of our operating results reflects the Company's acquisition of ASP Acuren Holdings, Inc. ('ASP Acuren' or the 'ASP Acuren Acquisition'). The period from January 1, 2025 through March 31, 2025, is referred to as the 'Successor' period and the period from January 1, 2024 through March 31, 2024 is referred to as the 'Predecessor' period.
Tal Pizzey, CEO of Acuren stated: 'We delivered 7.2% organic growth in the quarter, highlighting the resilience of the recurring nature of our revenues even in a cautious economic environment. We also delivered solid free cash flow, further solidified our balance sheet with the repricing of our debt, and continued to realize benefits from recent successful acquisitions. First quarter margins reflect a higher contribution from our run and maintain site work which is highly recurring in nature with lower margins than our overall mix. We remain focused on organic growth and pricing discipline, which is underscored by our unchanged full year outlook. Through differentiated services, a customer-first mindset, and operational efficiency, we believe we are well-positioned to unlock long-term shareholder value.'
First Quarter 2025 Highlights
Successor Revenue of $234.2 million represents a 5.0% increase compared to $223.1 million of Predecessor Revenue in the prior Predecessor quarter. The increase is driven primarily by strong organic performance, including higher run and maintain revenue and service line expansion.
Successor Net Loss of $25.9 million compared to Predecessor Net Loss of $1.3 million in the prior Predecessor quarter. The Successor Net Loss for the 2025 quarter includes increased depreciation and amortization related to the ASP Acuren Acquisition, a valuation allowance on a deferred tax asset, and planned public company and business transformation costs.
Successor Adjusted EBITDA of $25.9 million compared to $35.5 million in the prior Predecessor quarter. Successor Adjusted EBITDA margin of 11.0%, compared to 15.9% in the prior Predecessor quarter. The decreases are primarily attributable to planned public company costs in the Successor quarter, along with certain high margin, discreet activities in the prior Predecessor quarter partially offset by a higher contribution to revenue from our run and maintain customer sites in the Successor quarter.
Robert A.E. Franklin, Co-Chairman of Acuren commented: 'Acuren's start to 2025 demonstrates the company's operational discipline and resilience. Our strong cash flow generation highlights the fundamental strength of our business model, while our robust balance sheet gives us the flexibility to pursue value-enhancing initiatives while maintaining our commitment to financial discipline. As we move forward, we remain focused on delivering sustainable growth, expanding margins, and continuing to build a premier testing, inspection, certification and compliance organization.'
Capital Resources and Liquidity
At March 31, 2025, the Company had total liquidity of $224.9 million, including cash and cash equivalents of $155.7 million plus undrawn capacity on the Company's $75.0 million revolving credit facility. Total term loan debt was $752.4 million, net of debt issuance costs at quarter end. At March 31, 2025, the Company's basic and diluted shares of common stock outstanding were 121,476,215 and 122,476,215, respectively.
Guidance
Acuren reiterates its full-year 2025 expectation for revenue growth to be in the low-to-mid-single digit percent range as compared to full year 2024.
Merger with NV5
In a separate press release issued today, Acuren and NV5 Global, Inc. (Nasdaq: NVEE) ('NV5') announced that they have entered into a definitive agreement to combine the two companies.
Webcast and Conference Call
Acuren will hold a webcast/dial-in conference call to discuss its financial results at 8:30 a.m. ET (7:30 a.m. CT) on Thursday, May 15, 2025. Participants on the call will include Talman Pizzey, Chief Executive Officer; Kristin Schultes, Chief Financial Officer and Robert A.E. Franklin, Co-Chairman.
To listen to the call by telephone, please dial 877-407-0789 or 201-689-8562. You may also attend and view the presentation via webcast by accessing the following URL:
https://viavid.webcasts.com/starthere.jsp?ei=1715442&tp_key=008473ca2a
A replay of the call will be available shortly after completion of the live call/webcast via the webcast link above.
About Acuren Corporation
Acuren is a leading provider of critical asset integrity services. The company operates primarily in North America serving a broad range of industrial markets. It provides these essential and often compliance-mandated (often at customer locations) services in the industrial space and is focused on the recurring maintenance needs of its customers. The work Acuren does fits in the service category referred to as Testing, Inspection, Certification, and Compliance (TICC) including Nondestructive Testing (NDT) in the field and the laboratory and in-lab destructive testing capabilities. More information can be found at https://www.acuren.com/.
Forward-Looking Statements
In this press release the Company may discuss events or results that have not yet occurred or been realized, commonly referred to as forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of Acuren Corporation ('Acuren' or the 'Company'). Such discussion and statements may contain words such as 'expect,' 'anticipate,' 'will,' 'should,' 'believe,' 'intend,' 'plan,' 'estimate,' 'predict,' 'seek,' 'continue,' 'pro forma' 'outlook,' 'may,' 'might,' 'should,' 'can have,' 'have,' 'likely,' 'potential,' 'target,' 'indicative,' 'illustrative,' and variations of such words and similar expressions, and relate in this press release, without limitation, to statements, beliefs, projections and expectations about future events, including, among other things, the Company's (i) ability to deliver its long-term shareholder value and sustainable growth and expand margins, (ii) ability to build a premier testing, inspection, certification and compliance organization and create value for all stakeholders, (iii) strong balance sheet, pricing discipline, and organic growth, (iv) 2025 full year guidance for revenue growth and Adjusted EBITDA, and (v) expectations regarding the impact of tariffs. Such statements are based on the Company's expectations, intentions and projections regarding the Company's future performance, anticipated events or trends and other matters that are not historical facts.
These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements, including, among others, (i) economic conditions affecting the industries we serve, including the construction industry and the energy sector, as well as general economic conditions; (ii) the ability and willingness of customers to invest in infrastructure projects; (iii) a decline in demand for our services or for the products and services of our customers; (iv) the fact that our revenues are derived primarily from contracts with durations of less than six months and the risk that customers will not renew or enter into new contracts; (v) our ability to successfully acquire other businesses, successfully integrate acquired businesses into our operations and manage the risks and potential liabilities associated with those acquisitions; (vi) our ability to compete successfully in the industries and markets we serve; (vii) our ability to properly manage and accurately estimate costs associated with specific customer projects, in particular for arrangements with fixed price terms; (viii) increases in the cost, or reductions in the supply, of the materials we use in our business and for which we bear the risk of such increases; (ix) the inherently dangerous nature of the services we provide and the risks of potential liability; (x) the seasonality of our business and the impact of weather conditions; (xi) our ability to remediate any material weaknesses; (xii) the impact of health, safety and environmental laws and regulations, and the costs associated with compliance with such laws and regulations; and (xiii) our substantial level of indebtedness and the effect of restrictions on our operations set forth in the documents that govern such indebtedness. For a detailed discussion of cautionary statements and risks that may affect the Company's future results of operations and financial results, please refer to the Company's filings with the SEC, including, but not limited to, the risk factors in the Company's Annual Report on Form 10-K for the year ended December 31, 2024 which was filed with the SEC on March 27, 2025, and any amendments thereto. Forward-looking statements included in this press release speak only as of the date hereof and, except as required by applicable law, the Company does not undertake any obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or circumstances after the date of this press release.
Non-GAAP Financial Measures
This press release contains Adjusted Gross Profit, Adjusted Gross Profit Margin, Adjusted EBITDA, Adjusted EBITDA Margin, Organic Change in Service Revenue, and Adjusted Selling, General and Administrative ('SG&A') expenses which are non-U.S. GAAP financial measures within the meaning of Regulation G promulgated by the Securities and Exchange Commission.
As used in this press release, Adjusted Gross Profit is defined as Gross Profit less depreciation expense included in cost of revenue for the periods presented. Adjusted Gross Profit Margin is defined as Gross Profit divided by Revenue. EBITDA is defined as earnings before interest, taxes, depreciation and amortization for the periods presented and Adjusted EBITDA is defined as EBITDA excluding the impact of certain non-cash and other specifically identified items for the periods presented. Adjusted EBITDA Margin is defined as Adjusted EBITDA divided by Revenue. Adjusted SG&A is defined as SG&A less depreciation and amortization and the impact of certain non-cash and other specifically identified items for the periods presented. Organic change in service revenues provides a consistent basis for a year-over-year comparison in net revenues as it excludes the impacts of material acquisitions, divestitures, and the impact of changes due to foreign currency translation.
The Company uses these non-GAAP financial measures and additional financial information both in explaining its results to shareholders and the investment community and in its internal evaluation and management of its businesses. The Company's management believes that these non-GAAP financial measures and the information they provide are useful to investors since these measures (a) permit investors to view the Company's performance using the same tools that management uses to evaluate the Company's past performance, reportable business segments and prospects for future performance, (b) permit investors to compare the Company with its peers, (c) determines certain elements of management's incentive compensation, and (d) provide consistent period-to-period comparisons of the results.
While the Company believes these non-GAAP measures are useful in evaluating the Company's performance, this information should be considered as supplemental in nature and not as a substitute for or superior to the related financial information prepared in accordance with GAAP. Additionally, these non-GAAP financial measures may differ from similar measures presented by other companies. A reconciliation of these non-GAAP financial measures is included later in this press release.
Acuren Corporation
Consolidated Statements of Operations and Comprehensive Income (Loss)
(amounts in thousands, except share and per share data)
(Unaudited)
Three Months Ended March 31,
Successor
Predecessor
2025
2024
Service revenue
$
234,215
$
223,062
Cost of revenue
190,546
167,214
Gross profit
43,669
55,848
Selling, general and administrative expenses
52,458
41,854
Transaction costs
651
—
Income (loss) from operations
(9,440
)
13,994
Interest expense, net
16,007
15,982
Other income, net
(1,119
)
(7
)
Loss before provision for income taxes
(24,328
)
(1,981
)
Provision (benefit) for income taxes
1,465
(710
)
Net loss
(25,793
)
(1,271
)
Other comprehensive income (loss):
Foreign currency translation adjustments
2,561
(9,578
)
Total other comprehensive income (loss)
2,561
(9,578
)
Total comprehensive loss
($
23,232
)
($
10,849
)
Net loss per share:
Basic loss per Common Share and Series A Preferred Share
($
0.21
)
—
Diluted loss per Common Share and Series A Preferred Share
($
0.21
)
—
Basic loss per Common Share
—
($
0.25
)
Diluted loss per Common Share
—
($
0.25
)
Weighted average shares outstanding:
Common Stock outstanding, basic
121,476,215
5,024,802
Common Stock outstanding, diluted
122,476,215
5,024,802
Series A Preferred Stock outstanding, basic and diluted
1,000,000
—
Expand
Acuren Corporation
Condensed Consolidated Statements of Cash Flows
(amounts in thousands)
(Unaudited)
Three Months Ended March 31,
Successor
Predecessor
2025
2024
Cash flows from operating activities:
Net loss
($25,793
)
($1,271
)
Adjustments to reconcile net loss to net cash provided by operating activities:
Provision (benefit) for credit losses
(687
)
(265
)
Depreciation and amortization
28,599
19,093
Noncash lease expense
2,491
2,418
Share-based compensation expense
1,107
897
Amortization of deferred financing costs
828
1,022
Fair value adjustments on interest rate derivatives
—
2,089
Deferred income taxes
(4,320
)
2,251
Other
(212
)
(150
)
Changes in operating assets and liabilities, net of effects of acquisitions:
Accounts receivable
31,859
5,327
Prepaid expenses and other current assets
4,306
2,031
Accounts payable
3,433
(10,029
)
Accrued expenses and other current liabilities
(5,921
)
3,525
Operating lease obligations
(2,352
)
(2,468
)
Other assets and liabilities
(546
)
(3,548
)
Net cash provided by operating activities
32,792
20,922
Cash flows from investing activities:
Purchases of property, plant and equipment
(4,476
)
(5,544
)
Proceeds from sale of property, plant and equipment
293
277
Acquisition of businesses, net of cash acquired
(8,030
)
(29,094
)
Net cash used in investing activities
(12,213
)
(34,361
)
Cash flows from financing activities:
Borrowings under long-term debt
—
20,000
Repayments of long-term debt
(1,932
)
—
Payments of debt issuance costs
(1,165
)
(1,820
)
Principal payments on finance lease obligations
(2,508
)
(2,479
)
Net cash provided by (used in) financing activities
(5,605
)
15,701
Net effect of exchange rate fluctuations on cash and cash equivalents
1,631
549
Net change in cash and cash equivalents
16,605
2,811
Cash and cash equivalents
Beginning of period
139,134
87,061
End of period
$
155,739
$
89,872
Expand
Acuren Corporation
(amounts in thousands)
(Unaudited)
Three Months Ended March 31,
Successor
2025
Predecessor
2024
Gross profit
43,669
55,848
Depreciation expense included in cost of revenue
15,362
9,061
Adjusted gross profit
59,031
64,909
Adjusted gross margin percentage (1)
25.2
%
29.1
%
Expand
1.
The Adjusted Gross margin percentage is calculated as Adjusted Gross profit divided by revenues for the applicable period
Expand
Acuren Corporation
Reconciliation of Adjusted EBITDA to Net Income (Loss)
(amounts in thousands)
(Unaudited)
Three Months Ended March 31,
Successor
Predecessor
Net loss
$
(25,793
)
$
(1,271
)
Provision (benefit) for income taxes
1,465
(710
)
Interest expense, net
16,007
15,982
Depreciation and amortization expense
28,599
19,093
Adjustments
Predecessor seller-related expenses and stock compensation (1)
—
1,744
Acquisition related transaction and integration expenses (2)
858
134
ASP Acuren transaction related expenses (3)
467
—
Public company business transformation costs (4)
2,650
—
Non cash stock compensation expense (5)
1,108
—
Other non-recurring charges (6)
491
537
Adjusted EBITDA
25,852
35,509
Adjusted EBITDA margin (7)
11.0
%
15.9
%
Expand
1.
Adjustment to add back expenses related primarily to the previous owner's compensation and stock incentive plans.
2.
Adjustment to add back transaction and acquisition integration related costs and similar items for acquisitions not including the acquisition of ASP Acuren.
3.
Adjustment to add back the transaction related expenses for the ASP Acuren Acquisition.
4.
Adjustment to reflect the elimination of non-recurring costs related to public company business transformation.
5.
Adjustment to add back stock compensation expense.
6.
Adjustment to add back other non-recurring charges including restructuring charges, IT development charges and certain gains, losses and balance adjustments.
7.
The Adjusted EBITDA margin is calculated as Adjusted EBITDA divided by revenues for the applicable period.
Expand
1.
Represents the effect of foreign currency on reported net revenues, calculated as the difference between reported net revenues and net revenues at fixed currencies for both periods. Fixed currency amounts are based on translation into U.S. Dollars at fixed foreign currency exchange rates established by management.
2.
Amount represents the year-over-year change when comparing both years after eliminating the impact of fluctuations in foreign exchange rates by translating foreign currency denominated results at fixed foreign currency rates for both periods.
3.
Adjustment to exclude service revenue from material acquisitions from their respective dates of acquisition until the first year anniversary from date of acquisition.
Expand
1.
Adjustment to add back expenses related primarily to the previous owner's compensation and stock incentive plans.
2.
Adjustment to add back transaction and acquisition integration related costs and similar items for acquisitions not including the acquisition of ASP Acuren.
3.
Adjustment to add back the transaction related expenses for the ASP Acuren Acquisition.
4.
Adjustment to reflect the elimination of non-recurring costs related to public company business transformation.
5.
Adjustment to add back stock compensation expense.
6.
Adjustment to add back other non-recurring charges including restructuring charges, IT development charges and certain gains, losses and balance adjustments.
Expand
Acuren Corporation
2024 Interim Financial Information
(amounts in thousands)
(Unaudited)
Predecessor
Predecessor
Predecessor
Successor
Successor
Three months
ended March 31,
2024
Three months
ended June 30,
2024
One month
ended
July 30, 2024
Two months
ended September
30, 2024
Three months
ended December
31, 2024
Net income (loss)
$
(1,271
)
$
(5,450
)
$
(8,983
)
$
(89,824
)
$
(15,628
)
Provision (benefit) for income taxes
(710
)
7,909
(3,956
)
(2,097
)
(3,159
)
Interest expense, net
15,982
17,569
5,828
13,336
17,725
Depreciation and amortization expense
19,093
19,670
7,014
20,431
26,882
Adjustments
Predecessor seller-related expenses and stock compensation (1)
1,744
17,925
9,809
—
—
One time non-cash equity charges (2)
—
—
—
69,821
—
Acquisition related transaction and integration expenses (3)
134
1,918
797
(565
)
594
ASP Acuren transaction related expenses (4)
—
—
5,204
24,554
11,444
Non cash stock compensation expense (5)
—
—
—
336
1,817
Other non-recurring charges (6)
537
(430
)
539
(926
)
1,070
Adjusted EBITDA
35,509
59,111
16,252
35,066
40,745
Expand
1.
Adjustment to add back expenses related primarily to the previous owner's compensation and stock incentive plans.
2.
Adjustment to add back the one time non cash stock compensation expenses for Founder Preferred Shares and independent director stock options for which the performance target was achieved when the acquisition of ASP Acuren occurred.
3.
Adjustment to add back transaction and acquisition integration related costs and similar items for acquisitions not including the acquisition of ASP Acuren.
4.
Adjustment to add back the transaction related expenses for the ASP Acuren acquisition.
5.
Adjustment to add back stock compensation expense.
6.
Adjustment to add back other non-recurring charges including restructuring charges, IT development charges and certain gains, losses and balance adjustments.
Expand

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
28 minutes ago
- Business Wire
Spectrum Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights
LOS ANGELES--(BUSINESS WIRE)-- The DJS Law Group reminds investors of a class action lawsuit against Spectrum Pharmaceuticals, Inc. ('Spectrum' or 'the Company') (NASDAQ: SPPI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of SPPI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery. CLASS PERIOD: DEADLINE: September 24, 2025 CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. Spectrum's Pinnacle Study of poziotinib for the treatment of lung cancer was less positive than it portrayed to investors. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. If you are a shareholder who suffered a loss, contact us to participate. NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of SPPI during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. There is no cost or obligation to you to participate in this case. WHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results. Join the case to recover your losses. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.


Bloomberg
an hour ago
- Bloomberg
Cargill's Revenue Falls to 4-Year Low Amid Declining Crop Prices
Cargill Inc. 's revenue declined to the lowest in four years as the largest private company in the US continues to restructure in the face of declining crop prices and a shrinking American cattle herd. The Minneapolis-based company posted revenue of $154 billion in the year ended May 31, according to an annual report posted on its website. That's down from about $160 billion a year earlier and the lowest since 2021, when revenue was reported at $134 billion.


Business Wire
2 hours ago
- Business Wire
Deadline Approaching: Lineage, Inc. (LINE) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Lineage, Inc. ('Lineage' or the 'Company') (NASDAQ: LINE) common stock pursuant and/or traceable to the registration statement used in connection with the Company's July 2024 initial public offering (the 'IPO'). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN LINEAGE, INC. (LINE), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT. Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmith@ by telephone at (215) 638-4847 or visit our website at What Happened? In July 2024, Lineage conducted its IPO, selling over 65 million shares of common stock at $78 per share. On November 6, 2024, Lineage released its third quarter 2024 financial results, revealing that it had suffered a $543 million net loss during the quarter. On this news, Lineage's stock price fell $5.22, or 7.4%, to close at $65.79 per share on November 6, 2024, thereby injuring investors. Then, on January 14, 2025, The Wall Street Journal reported that Lineage was laying off employees due to reduced customer demand only six months after its IPO. Then, on April 7, 2025, Lineage announced the dismissal of its auditor, KPMG LLP. On this news, Lineage's stock price fell $5.29, or 9.9%, over two consecutive trading days, to close at $48.41 per share on April 8, 2025. Then, on April 30, 2025, Lineage reported first quarter 2025 financial results, including that '[t]otal revenue decreased (2.7)%' to $1.29 billion for the quarter. The Company stated it 'experienced more normal seasonal trends in the first quarter after multiple years of elevated inventory levels.' On this news, Lineage's stock price fell $8.16, or 14.62%, to close at $47.65 per share on April 30, 2025, thereby injuring investors further. On June 3, 2025, the Company stated at an Investor Conference that there has been 'pretty much flat demand' for Lineage's products and services and that the Company was operating in a 'flattish environment' in terms of demand. The price of Lineage stock has remained substantially below the IPO price at the time of this complaint's filing. What Is The Lawsuit About? The complaint filed in this class action alleges that the Registration Statement made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that Lineage was then experiencing sustained weakening in customer demand, as additional cold-storage supply had come on line, the Company's customers destocked a glut of excessive inventory built up during the COVID-19 pandemic, and the Company's customers shifted to maintaining leaner cold-storage inventories on a go-forward basis in response to changed consumer trends; (2) that Lineage had implemented price increases in the lead-up to the IPO that could not be sustained in light of the weakening demand environment facing the Company; (3) that Lineage was unable to effectively counteract the adverse trends listed in the foregoing through the use of minimum storage guarantees or as a result of operational efficiencies, technological improvements, or its purported competitive advantages; (4) that, as a result of the foregoing, rather than enjoying stable revenue growth, high occupancy rates, and steady rent escalation as represented in the Registration Statement, Lineage was in fact suffering from stagnant or falling revenue, occupancy rates, and rent prices; and (5) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times. If you purchased or otherwise acquired Lineage common stock pursuant and/or traceable to the IPO, you may move the Court no later than September 30, 2025 to ask the Court to appoint you as lead plaintiff if you meet certain legal requirements. Contact Us To Participate or Learn More: If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us: Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, Telephone: (215) 638-4847 Email: howardsmith@ Visit our website at: To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.